Anavex Life Sciences (AVXL) Operating Expenses (2016 - 2025)
Anavex Life Sciences (AVXL) posted Operating Expenses of $6.8 million for Q4 2025, down 37.46% sequentially from $10.8 million in Q3 2025, and down 50.1% YoY from $13.6 million in Q4 2024.
Anavex Life Sciences (AVXL) Operating Expenses (2016 - 2025) Analysis & Trends
Anavex Life Sciences has reported Operating Expenses for 10 years, with the latest figure at $6.8 million in Q4 2025.
- Quarterly Operating Expenses fell 50.1% year-over-year to $6.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44.6 million (down 19.05% YoY) and the FY2025 annual result came in at $51.4 million, down 2.78% from the prior year.
- Operating Expenses eased to $6.8 million in Q4 2025 per AVXL's latest filing, from $10.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $15.4 million in Q4 2022 and troughed at $6.8 million in Q4 2025.
- A 5-year average of $12.5 million and a median of $12.6 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2021 and 2025: Operating Expenses soared 122.41% in 2021, then slumped 50.1% in 2025.
- Over 5 years, Operating Expenses stood at $11.7 million in 2021, then surged by 31.22% to $15.4 million in 2022, then decreased by 26.04% to $11.4 million in 2023, then advanced by 19.46% to $13.6 million in 2024, then plunged by 50.1% to $6.8 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $6.8 million, $10.8 million, and $14.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Anavex Life Sciences | 298.40 Mn | 166.65 Mn | - | 6.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.78 Mn |
| Sep 30, 2025 | 10.84 Mn |
| Jun 30, 2025 | 14.46 Mn |
| Mar 31, 2025 | 12.51 Mn |
| Dec 31, 2024 | 13.59 Mn |
| Sep 30, 2024 | 14.27 Mn |
| Jun 30, 2024 | 14.60 Mn |
| Mar 31, 2024 | 12.62 Mn |
| Dec 31, 2023 | 11.38 Mn |
| Sep 30, 2023 | 12.66 Mn |
| Jun 30, 2023 | 13.53 Mn |
| Mar 31, 2023 | 14.19 Mn |
| Dec 31, 2022 | 15.38 Mn |
| Sep 30, 2022 | 15.28 Mn |
| Jun 30, 2022 | 12.46 Mn |
| Mar 31, 2022 | 11.52 Mn |
| Dec 31, 2021 | 11.72 Mn |
| Sep 30, 2021 | 12.25 Mn |
| Jun 30, 2021 | 11.40 Mn |
| Mar 31, 2021 | 8.95 Mn |